Oct 26 (Reuters) – Drug developers Aspen Neuroscience and Bambusa Therapeutics launched their US initial public offering roadshows on Monday, adding to a wave of issuers from the biotech industry that
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Siddharth Cavale NEW YORK, Oct 26 (Reuters) - Brent crude futures finished lower on…
By Jaspreet Singh Oct 26 (Reuters) - Meta Platforms said on Monday it plans to…
Oct 26 (Reuters) - Skydance is offering some employees a one-time voluntary buyout, according to…
Oct 26 (Reuters) - * DOORDASH NEARS DEAL TO BUY INSTACART IN $17 BILLION DEAL…
VIDEO SHOWS: ATP 500 VIENNA OPEN FIRST ROUND HIGHLIGHTS SHOWS: VIENNA, AUSTRIA (OCTOBER 26, 2026)…
(Adds further comments from interview, context in paragraphs 3-9) BRASILIA, Oct 26 (Reuters) - Brazil's…